Financial Gravity Asset Management’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10
Closed -$14 1750
2023
Q2
$14 Buy
+10
New +$106 ﹤0.01% 1517
2023
Q1
Sell
-9
Closed -$13 1647
2022
Q4
$13 Buy
+9
New +$127 ﹤0.01% 1352

Other funds holding TSVT

Financial Gravity Asset Management's TSVT Position: Q3 2023 in Review

Financial Gravity Asset Management sold out of 2seventy bio (TSVT) in Q3 2023, closing a stake of 10 shares — an estimated $14 sold.

Financial Gravity Asset Management first reported a position in TSVT in Q4 2022 and held it in 2 quarters. The position peaked at $14 in Q2 2023. 145 funds tracked by Wall St. Rank hold TSVT as of Q3 2023.

  • Financial Gravity Asset Management reported no remaining 2seventy bio position as of Q3 2023 after selling out during the quarter.
  • Financial Gravity Asset Management sold 10 2seventy bio shares in Q3 2023, an estimated $14.
  • Financial Gravity Asset Management first reported a position in 2seventy bio in Q4 2022 and held it in 2 quarters.
  • Financial Gravity Asset Management's 2seventy bio position peaked at $14 in Q2 2023.
  • 145 funds tracked by Wall St. Rank held 2seventy bio as of Q3 2023.

Based on Financial Gravity Asset Management's 13F filing for Q3 2023, filed 16 Nov 2023.